Healthcare Logistics Market to Hit USD 192.81 Billion by 2032, Driven by Rising Biopharma Demand, Cold Chain Expansion – SNS Insider

SNS Insider reported that global Healthcare Logistics Market was valued at USD 88.04 billion in 2023 and is projected to reach USD 192.81 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.07% from 2024 to 2032.

The U.S. market accounted for USD 26.66 billion in 2023 and is expected to reach USD 57.05 billion by 2032, supported by expanding pharmaceutical and biotechnology production, adoption of digital tracking systems, and the growing importance of temperature-controlled logistics.

Strong growth in biologics, vaccines, and medical device distribution, combined with regulatory pressure for supply chain transparency and the rapid integration of automation and data analytics, continues to transform the global healthcare logistics landscape. Increased investment in cold chain infrastructure and outsourcing of logistics functions to specialized third-party providers are major forces driving the market forward.

Get free Sample Report of Healthcare Logistics Market: https://www.snsinsider.com/sample-request/6668

Major Players in the Healthcare Logistics Market Include:

• McKesson Corporation
• Cardinal Health
• DHL Supply Chain
• UPS Healthcare
• FedEx HealthCare Solutions
• Owens & Minor, Inc.
• Baxter International Inc.
• Omnicell, Inc.
• Zipline International Inc.
• Stryker Corporation
• AmerisourceBergen (Cencora)
• Kuehne + Nagel International AG
• DB Schenker
• CEVA Logistics
• DSV (formerly Panalpina)
• GEODIS
• SF Express
• Sinotrans Limited
• Yusen Logistics

Healthcare Logistics Market Segment Insights

By Industry

The Biopharmaceutical segment dominated the healthcare logistics market with a 38.21% share in 2023, driven by the rising global demand for biologics, vaccines, and advanced therapies that require specialized temperature-controlled handling. Unlike traditional small-molecule drugs, biologics demand precise cold chain logistics and real-time monitoring to maintain product efficacy.

In 2023, biologics accounted for a significant share of new drug approvals, pushing logistics providers to expand cold storage networks. Major firms such as DHL and UPS Healthcare invested heavily in temperature-controlled facilities and integrated digital tracking systems, solidifying biopharma’s leadership within healthcare logistics.

By Service

The Warehousing and Storage segment led with a 68.40% market share in 2023, fueled by growing requirements for compliant and temperature-regulated storage for biologics, vaccines, and personalized medicines. Logistics companies developed advanced warehouse facilities equipped with automation, climate control, and digital inventory systems to support real-time tracking.

The growing trend toward e-commerce and just-in-time delivery also accelerated demand for strategically located warehouses. Companies such as Cardinal Health, McKesson, and DHL Supply Chain have made major investments in modernizing warehouse operations to meet industry standards and regulatory expectations.

By Supply Chain

The Non-Cold Chain segment dominated the market with a 70.19% share in 2023, reflecting the consistent need for transport of non-temperature-sensitive items such as over-the-counter medicines, surgical supplies, and diagnostic devices. These goods account for a large portion of total shipment volume and require broad distribution networks.

Non-cold chain logistics are less complex and more cost-effective, offering scalability and geographic reach in both developed and emerging markets. Enhanced tracking and regional warehousing have further streamlined distribution for this segment.

By Mode

The Outsourcing segment held an 83.20% share in 2023, as pharmaceutical and biotech firms increasingly rely on third-party logistics (3PL) providers to manage regulatory compliance, cold chain processes, and international distribution. Outsourcing enables companies to focus on R&D and commercialization while leveraging the expertise of logistics specialists.

Firms such as DHL, UPS Healthcare, and FedEx expanded their healthcare-dedicated networks, offering temperature-controlled transport, clinical trial logistics, and digital shipment visibility, making outsourcing the preferred mode for global manufacturers.

By End User

The Pharmaceutical and Biotechnological Companies segment led the market with a 63.10% share in 2023, reflecting their role as primary consumers of logistics services. These companies manufacture and distribute high-value, temperature-sensitive therapies that require precise handling. The rapid rollout of mRNA vaccines and advanced biologics further boosted demand for sophisticated supply chain solutions.

As regulatory oversight increases, these firms are partnering with logistics providers that offer validated, compliant, and digitally monitored operations to maintain integrity and safety across borders.

Regional Analysis

North America Leads While Asia Pacific Emerges as the Fastest-Growing Market in Healthcare Logistics

North America commanded a 43.06% share in 2023, supported by its mature healthcare infrastructure, major pharmaceutical production hubs, and extensive cold chain networks. The U.S. is the key contributor, with leading players such as Cardinal Health, McKesson, and UPS Healthcare operating advanced temperature-controlled transport and warehousing systems. Adoption of AI, IoT, and digital inventory management further strengthens the region’s logistics capabilities.

The Asia Pacific region is projected to record the fastest CAGR of 9.89% through 2032. Rising healthcare spending, pharmaceutical manufacturing expansion, and government investment in cold chain infrastructure are driving growth. Countries like India and China are strengthening logistics networks and digitalizing supply chains to support local production and exports.

Government programs such as India’s Production Linked Incentive (PLI) scheme encourage domestic manufacturing of drugs and medical devices, fueling demand for efficient logistics support.

Buy the Healthcare Logistics Market Report Now: https://www.snsinsider.com/checkout/6668

Recent Developments in the Healthcare Logistics Market

• In 2025, UPS Healthcare expanded its temperature-controlled facilities in Singapore and Germany to support global biologics transport.
• FedEx HealthCare Solutions introduced AI-powered tracking to enhance shipment transparency across temperature-sensitive lanes.
• McKesson Corporation upgraded its U.S. distribution centers with advanced robotics and warehouse automation.
• DHL Supply Chain announced new investments in life sciences logistics centers across North America and Europe.
• Zipline International expanded medical drone deliveries in Africa, enabling efficient vaccine and medicine transport to remote areas.

Statistical Insights

• Cold chain logistics accounted for nearly 30% of the healthcare logistics market value in 2023.
• Outsourced healthcare logistics are expected to surpass USD 150 billion by 2032.
• AI and IoT integration in healthcare logistics operations is projected to grow by over 15% annually through 2030.
• The U.S. handles over one-third of global healthcare product shipments, underscoring its central role in the global network.

Other Trending Reports

Deep Brain Stimulation [DBS] Devices Market

Recombinant Proteins Market

Respiratory Syncytial Virus (RSV) Therapeutics Market

Digital Dentistry Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Rohan Jadhav - Principal Consultant

Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Email: info@snsinsider.com